Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

ImmuPharma Shares Edge Higher: Why Is IMM Stock Back on Investors' Watchlists?

• IMM shares gained 1.39% on 9 July 2026, closing at 3.90 GBX.• ImmuPharma PLC has a market capitalization of approximately 23.99 million GBP, placing it in the small-cap segment.• The company develops novel therapeutics targeting autoimmune diseases and other unmet medical needs.• Clinical …

Ankur Sharma | 09 July 2026

Hemogenyx Pharmaceuticals Shares Rally: Why Is HEMO Stock Gaining Momentum?

• HEMO shares gained 5.81% on 9 July 2026, closing at 820.00 GBX.• Hemogenyx Pharmaceuticals PLC has a market capitalization of approximately 52.70 million GBP, placing it in the small-cap segment.• The company develops cell therapies and immunotherapy technologies targeting blood cancers and other …

Ankur Sharma | 09 July 2026

Sareum Holdings Shares Move Higher: Why Is SAR Stock in Focus?

• SAR shares gained 4.55% on 9 July 2026, closing at 23.00 GBX.• Sareum Holdings PLC has a market capitalization of approximately 30.48 million GBP, placing it in the small-cap segment.• The company focuses on developing innovative therapies for autoimmune diseases and cancer through …

Ankur Sharma | 09 July 2026

Scancell Holdings Shares Hold Steady: Why Is SCLP Stock Still on Investors' Radar?

• SCLP shares declined 0.18% on 9 July 2026, closing at 13.73 GBX.• Scancell Holdings PLC has a market capitalization of approximately 142.69 million GBP, placing it in the small-cap segment.• The company develops immunotherapies and vaccines targeting cancer and infectious diseases.• Clinical trial …

Ankur Sharma | 09 July 2026

Why Is LSE:OBD Back on Investors' Watchlists Following Its Focus on Blood-Based Cancer Diagnostics?

Oxford BioDynamics PLC (LSE:OBD) has remained firmly on investors' watchlists as healthcare systems increasingly adopt precision diagnostics, personalised medicine and non-invasive testing technologies.

Ankur Sharma | 09 July 2026

Could Thalia Therapeutics Become AIM's Next RNA Therapy Success Story After Its Transformational Deal?

Thalia Therapeutics PLC (LSE:THAT) has emerged as one of the more closely watched AIM-listed biotechnology companies following a series of significant corporate developments that have reshaped its long-term strategy.

Ankur Sharma | 09 July 2026

What Are Barings Emerging EMEA Opportunities PLC's Biggest Growth Catalysts?

Barings Emerging EMEA Opportunities PLC is a London-listed investment trust focused on generating long-term capital appreciation through investments across emerging Europe, the Middle East and Africa (EMEA). The trust invests in publicly listed companies operating in economies that offer higher long-term growth potential than …

Divya Sood | 09 July 2026

Is Spire Healthcare Expanding Its Competitive Advantage?

Spire Healthcare Group PLC (LSE:SPI) traded higher today as investors continued to focus on the company's resilient operating performance, improving patient demand, strong private healthcare trends and its long-term earnings outlook. Although daily share price movements are often influenced by broader market sentiment and …

Divya Sood | 09 July 2026

Renalytix Shares Edge Higher: Why Is RENX Stock on Investors' Radar?

• RENX shares gained 1.79% on 9 July 2026, closing at 2.85 GBX.• Renalytix Plc has a market capitalization of approximately 12.24 million GBP, placing it in the micro-cap segment.• The company develops diagnostic solutions focused on the early detection and management of kidney …

Ankur Sharma | 09 July 2026

Why Is LSE:SYNC Back in Focus After Major Clinical Progress Across Its Biotech Portfolio?

LSE:SYNC – Syncona Ltdhas once again become one of the UK's most closely watched healthcare investment companies as investors increasingly turn their attention towards biotechnology, gene therapy and innovative medicines.

Ankur Sharma | 09 July 2026
Support

Hi! How can we help you today?

Loading…